HOME >> BIOLOGY >> NEWS
GM seed may be more widespread than we think

Strict segregation would keep crops free of genetically modified seed. But is it possible?

CONCERN over the accidental planting of genetically modified seed on several farms in Europe reached fever pitch last week. And now a company in the US has warned that the problem is probably commonplace.

"My guess is that it happens all the time," says Jeffrey Smith, vice president of marketing and communications at Genetic ID of Fairfield, Iowa. The company, which screens agricultural produce for GM material, found that more than half of 20 random samples of conventional seed taken from American distributors contained some GM seed.

The latest European furore began with the news that farmers throughout the continent have planted conventional oilseed rape containing traces of a sterile GM variety known as RT 73, which has not been approved for commercial planting in Europe. In Britain alone, 9000 hectares were sown with the adulterated seed in 1999, followed by 4700 hectares this spring.

In other European countries, including France and Sweden, ministers have considered ordering the destruction of affected crops. Opponents of GM crops accused governments of allowing the release of such crops before their environmental impact had been properly evaluated.

But this week, Genetic ID told New Scientist that such contamination might be just the tip of the iceberg. It says that in tests done last year, but not widely publicised, 12 out of 20 random American consignments of conventional maize seed contained detectable traces of GM maize. Two of these contained almost 1 per cent GM maize. Pioneer Hi-Bred, the largest supplier of both conventional and GM seeds in the US, acknowledged that low levels of mingling are inevitable. "Absolute zero purity is not achieved in any agricultural produce anywhere in the food chain," says Doyle Karr, a spokesman for the company.

Karr says Pioneer's conventional maize seeds exported
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
23-May-2000


Page: 1 2 3

Related biology news :

1. Circadian influence in plants more widespread than previously thought
2. Arsenic in New England wells more widespread than thought
3. First drug developed for widespread use against botulism
4. New technologies to battle little known, widespread cattle disease
5. Ethiopian fossil skull indicates Homo erectus was single, widespread species 1 million years ago
6. Hepatitis E virus infection may be widespread in rats
7. Rare deficit maps thinking circuitry
8. Muscles are smarter than you think
9. What are babies thinking before they start talking?
10. New book urges ecologists to think outside the helmet
11. UF researcher: Animals think in their own way, but unlike humans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the company has ... Sciences Awards as "Most Outstanding in eClinical Solutions" ... of recognition and growth for MedNet, which has effectively ... iMedNet ™ , MedNet,s flagship eClinical ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the ... President of Medical Affairs.  Dr. Coleman will ... the company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers ... genetic sequencing data and clinical decision support, from quality control ... , ...
(Date:11/30/2016)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... announce the formation of EyGen, Ltd. a new ... through proof of concept. EyGen,s lead asset is ... Limited and being developed for topical ophthalmic delivery ... diseases. This agent has the potential to become ...
(Date:11/30/2016)... 2016  The Allen Institute for Cell Science ... publicly available collection of gene edited, fluorescently tagged ... cellular structures with unprecedented clarity. Distributed through the ... are a crucial first step toward visualizing the ... makes human cells healthy and what goes wrong ...
(Date:11/30/2016)... Nov. 30, 2016  Tempus, a technology company ... and Penn,s Abramson Cancer Center have partnered to ... response to immunotherapy treatment based on next generation ... part of a research collaboration, Tempus will provide ... cancer patient data to Penn. Utilizing next-generation sequencing, ...
Breaking Biology Technology:
Cached News: